Answers are grounded in this paper and cite their sources.
Validation study demonstrates improved genetic risk prediction for complex traits across biobanks, suggesting fine-tuning pre-trained polygenic risk scores enhances accuracy.
Polygenic risk scores are widely used for predicting genetic risk across complex diseases and traits, and several pre-trained models have been developed. Few approaches leverage these pre-trained polygenic risk scores to further refine predictive performance. Here, we present Adaptive Boosting of pre-trained Polygenic Risk Socres, a fine-tuning framework that refines pre-trained polygenic risk score models through adaptive variable selection and model boosting to identify additional predictive signals that may not be fully captured by the original models. Simulations show that our framework can identify signals orthogonal to pre-trained polygenic risk scores while controlling false discovery rates. Using UK Biobank data, we fine-tune pre-trained polygenic risk scores for binary diseases and continuous traits, and validate the results across three independent datasets: All of Us, eMERGE, and Penn Medicine Biobank. Real data analyses show that Adaptive Boosting of pre-trained Polygenic Risk Scores achieves statistically significant improvements in several scenarios while maintaining competitive performance in others. Several pre-trained PRS models exist, but they are not often used to refine prediction further. Here, the authors develop a pre-train and fine-tune framework to improve polygenic risk prediction using these pre-trained models.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: